Home » Topics » Disease categories and therapies » Immune

Immune
RSS

HHS announces intention to out-license vaccine technology

Dec. 19, 1997

LJP-394 binds to B-cells in lupus patients

Dec. 17, 1997

La Jolla evaluates Toleragan compounds for xenotransplantation

Dec. 17, 1997

SmithKline Beecham licenses rotavirus vaccine

Dec. 16, 1997

Pediatric rotavirus vaccine approval recommended

Dec. 15, 1997

First FDA approval for humanized MAb: Zenapax for renal transplant patients

Dec. 12, 1997

MedImmune and SKB establish worldwide alliance for HPV vaccines

Dec. 12, 1997

EU approves ciclosporin bulk substance

Dec. 12, 1997

Epstein-Barr virus vaccine enters phase I

Dec. 8, 1997

SangStat signs ciclosporin agreement with Amgen

Dec. 8, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 27, 2026.
Detecting the invisible: minimal residual disease at AACR 2026
BioWorld Science
Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
AACR 2026: The age of agentic AI in oncology
BioWorld Science
New Approach Methodologies (NAMs) for drug development are transforming biomedical research by replacing or complementing animal models. More than 90% of...
Chengdu Mfs Pharma synthesizes new compounds for pain
BioWorld Science
Chengdu Mfs Pharma Co. Ltd. has prepared and tested compounds for the potential treatment of pain, sleep disorder and status epilepticus epilepsy as well as for...